Microdomain-Specific Modulation of L-type Calcium Channels Leads to Triggered Ventricular Arrhythmia in Heart Failure by Sanchez-Alonso, JL et al.
 DOI: 10.1161/CIRCRESAHA.116.308698   1 
Microdomain-Specific Modulation of L-type Calcium Channels Leads to Triggered 
Ventricular Arrhythmia in Heart Failure 
 
Jose L. Sanchez-Alonso1, Anamika Bhargava1,7, Thomas O'Hara,2, Alexey V. Glukhov1, Sophie 
Schobesberger1,6, Navneet Bhogal1,  Markus B. Sikkel1, Catherine Mansfield1, Yuri E. Korchev3, Alexander 
R. Lyon1,4, Prakash P. Punjabi1,5,Viacheslav. O. Nikolaev6, Natalia A. Trayanova2, Julia Gorelik1 
 
1Department of Cardiovascular Sciences, Imperial Centre for Translational and Experimental Medicine, 
National Heart and Lung Institute; Imperial College London; London, W120NN, UK; 2Department of 
Biomedical Engineering and Institute for Computational Medicine; Johns Hopkins University; Baltimore, 
MD, 21218, USA; 3Department of Medicine, Imperial College London, London, W12 0NN, UK; 4 NIHR 
Cardiovascular Biomedical Research Unit; Royal Brompton Hospital; London, SW36NP; UK; 
5Department of Cardiothoracic Surgery, Hammersmith Hospital, National Heart and Lung Institute; 
Imperial College London, London, W12 0NN; UK; 6Institute of Experimental Cardiovascular Research, 
University Medical Center Hamburg-Eppendorf; Hamburg, D-20246; Germany, and; 7Department of 
Biotechnology, Indian Institute of Technology Hyderabad, Kandi, Sangareddy 502285, Telangana, India. 
 
J.L.S-A., A.B., and T.O. contributed equally to this work. 
 
Running title:  L-type Calcium Channel Relocation in Heart Failure 
 
 
 
 
 
 
 
 
Subject Terms: 
Electrophysiology  
Heart Failure 
Imaging  
Ion Channels/Membrane Transport  
Translational Studies  
 
 
Address correspondence to: 
Dr Julia Gorelik 
Department of Cardiovascular Sciences 
Imperial Centre for Translational and Experimental Medicine 
National Heart and Lung Institute 
Imperial College London 
London, W120NN 
United Kingdom 
Tel: +44 (0)20 7594 2736 
Fax: 44 (0)20 7594 3653 
j.gorelik@imperial.ac.uk  
 
 
In July 2016, the average time from submission to first decision for all original research papers submitted to 
Circulation Research was 13.27 days. 
 by guest on Septem
ber 1, 2016
http://circres.ahajournals.org/
D
ow
nloaded from
 
 by guest on Septem
ber 1, 2016
http://circres.ahajournals.org/
D
ow
nloaded from
 
 by guest on Septem
ber 1, 2016
http://circres.ahajournals.org/
D
ow
nloaded from
 
 by guest on Septem
ber 1, 2016
http://circres.ahajournals.org/
D
ow
nloaded from
 
 by guest on Septem
ber 1, 2016
http://circres.ahajournals.org/
D
ow
nloaded from
 
 by guest on Septem
ber 1, 2016
http://circres.ahajournals.org/
D
ow
nloaded from
 
 by guest on Septem
ber 1, 2016
http://circres.ahajournals.org/
D
ow
nloaded from
 
 by guest on Septem
ber 1, 2016
http://circres.ahajournals.org/
D
ow
nloaded from
 
 by guest on Septem
ber 1, 2016
http://circres.ahajournals.org/
D
ow
nloaded from
 
 by guest on Septem
ber 1, 2016
http://circres.ahajournals.org/
D
ow
nloaded from
 
 by guest on Septem
ber 1, 2016
http://circres.ahajournals.org/
D
ow
nloaded from
 
 by guest on Septem
ber 1, 2016
http://circres.ahajournals.org/
D
ow
nloaded from
 
 by guest on Septem
ber 1, 2016
http://circres.ahajournals.org/
D
ow
nloaded from
 
 by guest on Septem
ber 1, 2016
http://circres.ahajournals.org/
D
ow
nloaded from
 
 by guest on Septem
ber 1, 2016
http://circres.ahajournals.org/
D
ow
nloaded from
 
 by guest on Septem
ber 1, 2016
http://circres.ahajournals.org/
D
ow
nloaded from
 
 by guest on Septem
ber 1, 2016
http://circres.ahajournals.org/
D
ow
nloaded from
 
 by guest on Septem
ber 1, 2016
http://circres.ahajournals.org/
D
ow
nloaded from
 
 by guest on Septem
ber 1, 2016
http://circres.ahajournals.org/
D
ow
nloaded from
 
 by guest on Septem
ber 1, 2016
http://circres.ahajournals.org/
D
ow
nloaded from
 
 by guest on Septem
ber 1, 2016
http://circres.ahajournals.org/
D
ow
nloaded from
 
 by guest on Septem
ber 1, 2016
http://circres.ahajournals.org/
D
ow
nloaded from
 
 by guest on Septem
ber 1, 2016
http://circres.ahajournals.org/
D
ow
nloaded from
 
 by guest on Septem
ber 1, 2016
http://circres.ahajournals.org/
D
ow
nloaded from
 
 by guest on Septem
ber 1, 2016
http://circres.ahajournals.org/
D
ow
nloaded from
 
 by guest on Septem
ber 1, 2016
http://circres.ahajournals.org/
D
ow
nloaded from
 
 by guest on Septem
ber 1, 2016
http://circres.ahajournals.org/
D
ow
nloaded from
 
 by guest on Septem
ber 1, 2016
http://circres.ahajournals.org/
D
ow
nloaded from
 
 by guest on Septem
ber 1, 2016
http://circres.ahajournals.org/
D
ow
nloaded from
 
 by guest on Septem
ber 1, 2016
http://circres.ahajournals.org/
D
ow
nloaded from
 
 by guest on Septem
ber 1, 2016
http://circres.ahajournals.org/
D
ow
nloaded from
 
 DOI: 10.1161/CIRCRESAHA.116.308698   2 
ABSTRACT 
 
Rationale: Disruption in subcellular targeting of Ca2+ signaling complexes secondary to changes in cardiac 
myocyte structure may contribute to the pathophysiology of a variety of cardiac diseases, including heart 
failure (HF) and certain arrhythmias. 
 
Objective: To explore microdomain-targeted remodeling of ventricular L-type Ca2+ channels (LTCCs) in 
HF. 
Methods and Results: Super-resolution scanning patch-clamp, confocal and fluorescence microscopy were 
used to explore distribution of single LTCCs in different membrane microdomains of non-failing and failing 
human and rat ventricular myocytes. Disruption of membrane structure in both species led to re-distribution 
of functional LTCCs from their canonical location in transversal tubules (T-tubules) to the non-native crest 
of the sarcolemma, where their open probability (Po) was dramatically increased (0.034±0.011 vs 
0.154±0.027, P<0.001). High Po was linked to enhanced calcium-calmodulin kinase II (CaMKII)-mediated 
phosphorylation in non-native microdomains and resulted in an elevated ICa,L window current which 
contributed to the development of early afterdepolarizations (EADs). A novel model of LTCC function in 
HF was developed; following its validation with experimental data, the model was used to ascertain how 
HF–induced T-tubule loss led to altered LTCC function and EADs. The HF myocyte model was then 
implemented in a 3D left ventricle model, demonstrating that such EADs can propagate and initiate 
reentrant arrhythmias. 
 
Conclusion: Microdomain-targeted remodeling of LTCC properties is an important event in pathways that 
may contribute to ventricular arrhythmogenesis in the settings of HF-associated remodeling. This extends 
beyond the classical concept of electrical remodelling in HF and adds a new dimension to cardiovascular 
disease. 
 
Keywords:  
L-type calcium channel, microdomain, super-resolution scanning patch-clamp, heart failure, modeling. 
 
Nonstandard Abbreviations and Acronyms: 
 
HF   heart failure 
LTCC   L-type Ca2+ channels 
RyRs   ryanodine receptors 
CaMKII  calcium/calmodulin kinase II 
MI   myocardial infarction 
SICM   scanning ion conductance microscopy 
TT   T-tubule 
EADs   early afterdepolarizations 
AP    action potential 
Po   open probability 
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INTRODUCTION 
 
Heart failure (HF) is a major cause of morbidity and mortality, contributing significantly to global 
health expenditure. Sudden death due to arrhythmia is responsible for over 50% of deaths among HF 
patients and therefore preventing arrhythmia and ameliorating the risk of sudden cardiac death secondary 
to HF is a paramount clinical need1, 2. Pathophysiological remodeling of cardiac function in HF occurs at 
multiple levels and includes the alterations in ion channel profile, Ca2+-handling proteins, and proteins 
mediating cell-cell coupling, predisposing to arrhythmias3-7. Recent studies have demonstrated that 
disruption of proper cellular organization accompanied by a progressive loss of transverse tubule (T-tubule, 
TT) microdomains in HF, may also have an impact on calcium cycling thus promoting the development of 
arrhythmogenic triggers8. Specifically, it has been hypothesized9, 10 that the communication between L-type 
Ca2+ channels (LTCCs) and ryanodine receptors (RyRs) is impaired in HF, perhaps indicating that LTCCs 
are less strictly confined to TTs. In addition, LTCC protein phosphorylation defects have been identified in 
HF3, 11. Therefore, we hypothesized that there is altered distribution of single LTCCs in cellular 
microdomains in HF following TT degradation, which results in channel dysfunction critically contributing 
to the development of arrhythmogenic triggers. 
 
Here, we used the super-resolution scanning patch-clamp technique12 to probe the microdomain-
specific localization of functional LTCCs with nano-spatial resolution in normal and failing ventricular 
cardiac myocytes. We showed, in failing cells, dislocation of functional LTCCs to the sarcolemma surface 
(or “crest” membrane, a term based on micrograph topography in contrast to TT), where they are rarely 
present in healthy cardiac myocytes. Obtaining evidence from multiple imaging modalities, 
electrophysiology and biochemistry, we discovered that these relocated channels exhibit higher open 
probability (Po) and phosphorylation status, which we found to be linked to enhanced activity of calcium-
calmodulin kinase II (CaMKII). The experiments were complemented by the development and use of a 
novel accurate HF computational model which also includes single channel behaviour to ascertain that 
LTCC relocation to the cell crest combined with enhanced CaMKII activity gives rise to the measured Po 
values. The model then demonstrated how this abnormal behaviour leads to cell-level oscillations in 
membrane voltage and development of arrhythmogenic triggers, and how these propagate to become 
arrhythmias at the organ level. The combined experimental/simulation approach presented here provides a 
comprehensive understanding of how disease-induced remodelling at the microdomain level is manifested 
into dysfunction at the organ level.  
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METHODS 
 
For full details of methods, please see the Online Supplement.  
 
Study approval. 
All animal experiments were carried out in accordance with the United Kingdom Home Office Animals 
(Scientific Procedures) Act 1986 Amendment Regulations 2012, incorporating the EU Directive 
2010/63/EU, which conforms to the Guide for the Care and Use of Laboratory Animals published by the 
US National Institutes of Health (NIH publication No. 85-23, revised 1996). Experiments on isolated human 
cardiac myocytes were approved by the Imperial College Institutional Review Board. 
 
Myocytes isolation and T-tubule characterization.  
Failing ventricular myocytes were isolated from 16-weeks post-MI rat model of HF (Online Figure I) and 
transplanted human hearts from patients with dilated cardiomyopathy (Online Table I). Age-matched sham 
operated rats and tissue biopsy human samples (Online Table II) were used to isolate control, non-failing 
cardiac myocytes. The subcellular TT system was visualized by confocal imaging of Di-8-ANEPPS stained 
cells6. Surface topography was characterized by scanning ion conductance microscopy (SICM) which uses 
a glass nano-pipette as sensitive probe as described elsewhere13. 
 
Super-resolution scanning patch-clamp with pipette clipping modification. 
After generating a topographical image of the cell surface by Scanning Ion Conductance Microscopy 
(SICM), the tip diameter of the pipette was widened by clipping13 to increase the area of attachment. The 
pipette was then lowered to a specific location until it touched the membrane and a high resistance seal was 
established. Single LTCC recordings were then performed in a cell-attached mode12. Controlled widening 
of the scanning nano-pipette tip is described in detail in the Online Supplement (Online Figure II and Online 
Figure III). 
 
Optical mapping of calcium activity. 
Optical mapping of cells loaded with the Ca2+-sensitive fluorescent dye Fluo-4AM via CMOS camera 
ULTIMA-L (SciMedia, USA Ltd., CA; 1,000 fps, 1.5-2 µm/pixel) was used to monitor localized changes 
in [Ca2+]i14. 
 
Western blot. 
Western blotting was done using monoclonal anti phospho-CaMKII (Thermo Scientific, MA1-047) α-
tubulin (Sigma, T9026) and GAPDH (Santa Cruz Biotechnology, FL-335) primary antibodies, followed by 
secondary anti-mouse antibodies ECL detection. Western blots were analysed by using ImageJ software. 
 
Statistical analysis. 
All graphs and statistical analysis were performed using either GraphPad prism 5 or Origin version 6.1. 
Normality was tested using the Kolmogorov-Smirnov test. In cases where data failed the normality test, the 
nonparametric Mann-Whitney test was used instead of the unpaired Student t-test. Statistical differences 
were assessed with Student t-test, Mann-Whitney test, Kruskal-Wallis test and Fisher’s exact test as 
appropriate. All data are expressed as mean ± standard error of the mean (SEM). A value of P<0.05 was 
considered statistically significant. 
 
Computational simulations. 
 
Single Channel Human L-type Ca2+ Current (ICa,L): Human ventricular cell electrophysiological behavior 
was represented by the O'Hara-Rudy model15. To model stochastic single channel behavior and determine 
the channel Po for comparison with human experimental data, for ICaL, we used its Markov-equivalent 
representation (Online Figure IV). To evolve the channel gating in response to a 1-s voltage change step 
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from resting state to -6.7mV, we used the Gillespie Exact Algorithm. Barium simulations matched barium 
experiments; with this as validation, we extrapolated to physiological calcium simulations. Example single 
channel sweeps are shown in Online Figure V. 
 
Once single channel current simulation results were generated and validated with experimental Po 
measurements, the ICa,L model was reverted back to a Hodgkin-Huxley formulation, retaining the CaMKII 
mode definitions and the behavior of the equivalent Markov version. Failing crest LTCCs were assumed to 
operate in CaMKII phosphorylated mode, based on experimental findings (see Results); their inactivation 
was via the slow gating mode. Failing LTCCs in TTs and control LTCCs were sensitive to standard 
CaMKII, and so inactivation was both fast and slow. Ensemble current computed by summation of single 
channel sweeps matched the deterministic Hodgkin-Huxley current (Online Figure VI). 
 
Models of human control and failing myocytes. 
The original O'Hara-Rudy myocyte model did not include a sub-sarcolemmal volume and thus did not allow 
for Ca2+ accumulation near the intracellular mouth of Crest LTCCs. We thus incorporated sub-sarcolemmal 
volume and related fluxes in the O'Hara-Rudy myocyte model based on the work of Grandi et al.16 and 
Shannon et al.17. Description of how this was done can be found in the Online Supplement. 
 
The original O'Hara-Rudy model included LTCCs exclusively at TT sites with dyadic intracellular face. 
Here, LTCCs in TTs sensed and contributed to dyadic Ca2+; channels newly added to the crest sensed and 
contributed to sub-sarcolemmal Ca2+. In each of TT and crest locations, LTCC permeability, PCa, 
representing whole-cell current density in TTs (PCaTT) and crest (PCaCrest) needed to be defined. We utilized 
experimental data obtained in this study to assign values to PCaTT and PCaCrest in control and failing human 
cells. The data used were: % occurrence of LTCCs, LTCC single channel current amplitude, and in failing 
cells, the degree of TT loss. Specific values for PCaTT and PCaCrest in control and failing human cells and 
the methodology by which they were assigned can be found in the Online Supplement. 
 
Outside of ICa,L several factors were included to recreate an accurate HF model. Descriptions of the 
formulations for Na+/Ca2+ Exchanger (NCX), representation of “orphaned” RyRs, and additional 
parameters representing others HF ion channel remodeling in the myocyte model can be also be found in 
the Online Supplement. 
 
Whole heart model. 
Organ-level simulations were performed using an MRI-based, anatomically-realistic human left ventricular 
model described previously18. Fiber orientation was assigned using a rule-based approach19. A 
computational mesh at a resolution of <300μm was generated using a validated approach20. Transmural cell 
types and conductivity were specified according to experimental data from human left ventricles7 (Online 
Figure VII). All parameters defining differences between the endocardial and epicardial cell variations of 
the O'Hara-Rudy model were scaled linearly across the ventricular walls to generate smoothly varying 
intermediate transmural types (10 segments defined using a Laplace-Dirichlet technique19. Pacing was 
delivered to the apex using a 2-cm diameter “electrode”. Electrophysiological simulation and numerical 
methods were identical to previous work18. Simulations were executed in monodomain mode using the 
CARP software package21, 22. 
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RESULTS 
 
HF is associated with loss of TTs with consequent alterations in LTCC spatial distribution and their 
functional properties. 
 
In both rat and human failing myocytes, we observed a significant decrease in internal TT density 
as compared to non-failing controls (Fig.1A and B; ~50% decrease in human, P<0.01), consistent with our 
previous findings6. Using SICM23 we found that the loss of TT correlates with the loss of surface structures 
as well (Fig.1C). Using Z-groove index as metric of surface integrity24, we found that in both human and 
rat failing myocytes surface structure was impaired (Fig.1D, ~40% reduction in human, P<0.01). We also 
detected reduction in the number of TT openings on the surface of failing cardiac myocytes, identified as 
dark circles in SICM images (~35% reduction in rat compared with control, P<0.001; Online Figure VIII). 
The loss of TT microdomains in failing myocytes was accompanied by altered spatial distribution of 
LTCCs. In control rat and human cardiac myocytes, LTCC activity was predominantly recorded in TTs 
(26.7% of 86 successful patches in rat and 28.6% of 21 successful patches in human cardiac myocytes 
showed LTCC activity) as opposed to the crest, where LTCC activity was rarely recorded (only 7.02% of 
57 successful patches in rat and 9.1% of 11 successful patches in human cells showed LTCC activity, 
Fig.2A and B, control). This confirmed our previous observation that the majority of functional LTCCs 
reside in the TTs12. Interestingly, LTCC occurrence along the Z-groove in rat cardiac myocytes was found 
to be intermediate between that in TT and Crest areas (15% of 20 successful patches) suggesting a density 
gradient of channels throughout the membrane.  
 
In contrast, in failing rat cardiac myocytes, LTCC current was recorded with similar frequency 
from both TTs and crests (20.4% of 54 successful patches in the TTs vs. 27.3% of 55 successful patches in 
the crest showed LTCC activity). In failing human cardiac myocytes, LTCC activity was even higher in the 
crest (27.3% of 22 successful patches in the TTs vs. 34.6% of 26 successful patches in the crest showed 
LTCC activity). This indicates that the distribution of functional LTCCs in the cardiac myocyte membrane 
was significantly altered in HF (Fig.2A and B, failing). 
 
Our experiments demonstrated that the HF-associated increase in the number of functional LTCCs 
outside of their native microdomains is accompanied by changes in their behavior. The LTCC Po was 
significantly elevated at the crest of failing myocytes as compared to that in crest of control myocytes in rat 
(Po at -6.7mV: 0.034±0.011 for control crest LTCCs vs. 0.153±0.026 for failing crest LTCCs, P<0.001; 
Fig.2D) and to that in TTs (0.053±0.005 for control TT LTCCs, P<0.001; 0.051±0.008 for failing TT 
LTCCs, P<0.01; Fig.2D and F). No changes in LTCC amplitude were observed in rat HF (Online Figure 
IX). In failing humans myocytes the Po was also significantly elevated at the crest as compared to that in 
TT of control and failing myocytes (Po at -6.7mV: 0.136±0.025 for failing crest LTCCs vs. 0.043±0.01 for 
control TT LTCCs, P<0.01 and vs. 0.042±0.021 for failing TT LTCCs, P<0.05; Fig.2C and E). We next 
endeavored to determine the mechanisms for LTCC functional changes in HF. 
 
Constitutive phosphorylation of LTCCs by cytoplasmic CaMKII leads to an increase in LTCC Po. 
 
Elevated phosphorylation can lead to increased Po of LTCCs25. Also, CaMKII activity is elevated 
in HF 26, and CaMKII can phosphorylated LTCCs at specific sites27. Therefore, we tested the hypothesis 
that the elevated activity of CaMKII in failing cardiac myocytes is responsible for phosphorylation and thus 
for the high Po of LTCCs in crest. 
  
Western blots indicated that the phosphorylated CaMKII T286 was higher in rat and human failing 
cells (Fig.3A-B); this p-CaMKII could be reduced following the application of the CaMKII inhibitor KN-
93 (Fig.3C; only rat myocytes were used in these experiments because of the paucity of human cells). As 
this residue is critical for the association and phosphorylation of the LTCC β2a subunit28, these data indicate 
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that LTCC phosphorylation should be increased. Besides, as we have shown in Fig.3D and Online Figure 
X local Po measurements demonstrate that LTCC Po in the crest of failing myocytes was reduced to a value 
similar to control following the application of KN-93 (from 0.153±0.026 for failing crest LTCCs to 
0.061±0.018 for failing crest LTCCs with KN-93, P<0.01). LTCCs from control cells or from TT failing 
cells were not affected by the inhibitor (Fig.3D), suggesting that the increase of CaMKII in failing cells had 
only effect on the failing myocyte crest, confirming our hypothesis. It has been shown that KN-93 can block 
LTCC directly under certain conditions29; to strengthen  our conclusion, AIP (Autocamptide-2 Related 
Inhibitor Peptide) was used on failing crest channels (Fig. 3B) and the results showed reduction of Po to 
control values (0.031±0.003, P<0.05 vs failing crest values), confirming our initial findings. 
 
Abnormal [Ca2+]i behavior in failing cells. 
 
Since HF-remodeling altered LTCC function in failing myocytes, we investigated whether there 
were concomitant changes in Ca2+ transients. Optical mapping of  Ca2+ transients at pacing rates of 0.5 Hz 
to 1 Hz revealed spontaneous [Ca2+]i oscillations which occurred during the decay phase in a greater 
proportion of failing cardiac myocytes compared to control (0.5Hz, ~45% failing vs. ~4% control P<0.05; 
Fig.4A). These Ca2+ oscillations were completely suppressed after treatment with KN-93 (Fig.4B) but not 
by KN-92 (Online Figure XI), an inactive analogue of KN-93. This suggests that the phosphorylation 
inhibition by KN-93 reduces the late LTCC current resulting from the increased LTCC Po at the cell crest 
and prevents [Ca2+]i oscillations. 
 
In rat failing cardiac myocytes, whole-cell patch clamp recordings (Online Figure XII) show 
prolonged action potential duration (APD) similar to what had been previously described in HF30-31. It has 
been shown that such action potential duration prolongation is accompanied by spontaneous occurrence of 
single and multiple early afterdepolarizations (EADs) in failing ventricular myocytes31. Oscillations in the 
Ca2+ transient such as shown in Fig.4, occurring in the settings of HF-associated ion channel remodeling, 
are also widely associated with EADs, a class of possible arrhythmogenic triggers in the heart32. However, 
linking Ca2+ transient oscillations to the development of HF-related arrhythmias at the organ level is a 
challenging task, both in terms of demonstrating by experimentation, across the spatial scales of structural 
hierarchy, and also causally, since electrotonic influences at the tissue/organ level could suppress cell-level 
triggers33. To prove that HF-induced changes in microdomain localization of LTCCs and their functional 
consequences at the cellular level could result in arrhythmia in the failing human heart, we developed and 
utilized a novel computational model of human HF that incorporated the experimental findings described 
above. 
 
Computational model based on single channel kinetics predicts the development of cellular-level triggers 
of arrhythmias in human HF. 
 
The human HF model was based on Monte Carlo simulations of the kinetics of a single human 
LTCC (see Online Supplement). Incorporating the experimental finding that in failing cardiac myocytes 
LTCCs at crests are CaMKII-phosphorylated, we calculated Po values in TTs and crests in control and 
failing human myocytes (Fig.5A, example sweeps in Online Figure V). Simulations were able to relate 
LTCC phosphorylation at crests to the elevated local Po value. The close match between simulation and 
experimental results served as a validation of the model, allowing us to use simulations to explore the 
downstream effect of LTCC functional changes. 
 
Simulated human whole-cell Ca2+current is of similar magnitude in failing and control cells, 
consistent with previous findings34-37 and our results on failing rat cardiac myocytes (Online Figure XIII). 
Current decay is slower in failing myocytes compared to control (Fig.5B), suggesting a potential for de-
stabilization of repolarization. Slower decay is due to enhanced CaMKII phosphorylation of LTCC 
channels in the crest. Traces corresponding to TTs were nearly identical for failing and control cells with 
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regard to decay rate; however, TTs in failing myocytes were de-populated and thus current magnitude in 
TT was reduced relative to control. 
 
The LTCC kinetics model was incorporated, together with other HF electrophysiological 
alterations, in an action potential (AP) model of the human (endocardial) ventricular myocyte to determine 
the cell-level consequences of LTCC dysfunction. AP simulation results showed that EADs developed due 
to late L-type Ca2+ current appearance in failing myocytes only (Fig.6). Here, CaMKII was set to be 
maximal in the failing crest (validated by experimental data in Fig.5A), causing phosphorylation of all 
LTCCs there. CaMKII block eliminated L-type Ca2+ current appearance and EADs. These simulation 
results were supported by optical [Ca2+] recordings (Fig.4; Ca2+ transient oscillations in failing human cells 
were simulated at a pacing rate of 0.25Hz, which could be considered similar to 0.5Hz pacing in the rat15). 
Although EADs in isolated cells are potential ectopic triggers, their formation does not guarantee the 
occurrence of arrhythmogenic triggers or arrhythmias in the whole heart. We therefore conducted organ-
level simulations to test whether EADs resulting from HF-induced LTCC re-localization could form 
propagating triggers and result in arrhythmia in the heart using more physiological human heart rates, such 
as 1Hz. 
 
Computational model predicts the development of arrhythmias in the failing human ventricles. 
 
Simulation results in Online Figure XIV demonstrated that epicardial cells did not develop EADs 
for any of the simulated conditions, indicating that arrhythmia triggers in the failing heart were expected to 
develop in the endocardial layer.  
 
The formation of arrhythmogenic triggers and reentrant arrhythmia in the failing human heart is 
shown in Fig.7 (1Hz pacing with a single skipped beat; arrhythmia did not take place without a skipped 
beat at this pacing rate) and in the Online Video I. AP traces at 3 different endocardial locations are shown 
in Fig.7A; site “i” was the closest to the pacing location at the apex. In the control ventricles (Online Video 
II), wavefronts propagated in an organized fashion in response to each pacing stimulus (short horizontal 
gray lines relate stimuli, one-to-one, to resulting action potentials at sites throughout the ventricles). In the 
failing ventricles, EAD triggers appeared near site “ii” and propagated (dashed gray lines from EAD 
triggers towards triggered APs). Activation in the control ventricles was completed within 250 ms, 
undisturbed by the skipped beat (Fig.7B1 and B2). In contrast, activation took twice as long to excite the 
failing ventricles. Following the “skipped beat” pause, cells near site “ii” failed to repolarize, and an 
endocardial EAD trigger formed (Fig.7B1 and B2). As shown in Fig. 7C, triggered activity propagated from 
that location, resulting in reentrant arrhythmia. The skipped beat pause had no discernable effect on 
subsequent activity in the control model (results not shown). Simulations also showed that triggered activity 
and arrhythmias did not develop in the failing ventricles when CaMKII was blocked, or when crest LTCCs 
were made to sense dyadic [Ca2+], where Ca-dependent inactivation was enhanced. The whole-heart 
simulations thus demonstrated a causal link between HF-induced microdomain localization of LTCCs and 
arrhythmias in the failing human heart.  
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DISCUSSION 
 
This study adds a new dimension to the understanding of cardiovascular disease, highlighting 
microdomain-specific changes in LTCC function, which acts in concert with well-established changes in 
protein expression. The major discovery of this study is that a disruption in the delicately balanced dynamic 
interactions between LTCCs and their cellular microenvironment can lead to pathological changes in 
cellular physiology, and to a downstream dysfunction at the organ level. This novel concept may help to 
explain the molecular mechanisms of HF and other human diseases. 
 
Re-localization of LTCCs in heart failure. 
 
Here, for the first time, we provide direct evidence of the presence, in HF, of abnormally 
functioning LTCCs in the extradyadic space (crests) of ventricular cardiac myocytes, concurrent with 
changes in microdomain structure. These extradyadic LTCCs may lose the communication with the RyRs, 
as previous work has shown that RyR regularity and distribution do not change during heart failure38. Only 
LTCCs localized in the crest had abnormally high Po which contributed to the pathophysiology of HF 
suggesting that nanoscale changes in the location of proteins can be detrimental to their function. In fact, it 
has been proposed that the long open states of the LTCCs are particularly proarrhythmic in the setting of 
AP prolongation39, suggesting that the channels that we found in the crest of failing cells can be a source of 
arrhythmias. 
 
A number of studies in animal models of HF40-41 have demonstrated a reduction in whole-cell Ca2+ 
current and in the average LTCC density, which appears to be a consequence of the profound loss of TTs, 
but other studies did not find changes in whole-cell Ca2+ 42. Interestingly, Bryant et al. showed a decreased 
ICa density in the t-tubules and increased ICa density on the cell surface in rat HF ventricular myocytes38 
which supports our findings at the single channel level.  In human failing cardiac myocytes no significant 
changes in LTCC density have been observed34, 36, 37, however an impaired Cav1.2 trafficking to the TT cell 
membrane has been suggested43. Taking into account the increased Po of LTCC observed in our study 
(Fig.3) and in previous reports25, one would expect a reduction of the number of functional channels5, 
although we can’t exclude that a more complex mechanism could be involved. Impaired communication 
between LTCCs and RyRs, together with an increase in LTCC Po, may slow down the inactivation time, as 
demonstrated experimentally3.  
 
It remains an open question what is the precise location of functional LTCC on the crests of 
sarcolemma. Are they sparsely localized on the cell surface or do they organize in special membrane 
microdomains forming complexes with others proteins? It is plausible that these channels are located in 
caveolae domains on the plasma membrane of the crest, as we recently demonstrated for extratubular 
LTCCs in atrial myocytes44. Through the function of caveolae-based LTCCs is unknown, Makarewich et 
al. recently demonstrated that Ca2+ influx through LTCCs within caveolae signaling domains can activate 
pathological cardiac “hypertrophic” signaling, and this Ca2+ influx can be selectively blocked without 
reducing cardiac contractility45. Whether these channels are associated with the hyperphosphorylated 
LTCCs observed in our study and the extent to which they may contribute to EADs remain an open 
question. 
 
Microdomain dependent changes in CaMKII signaling. 
 
For the first time our study reports microdomain-dependent changes in CaMKII-mediated Ca2+ 
signaling in HF (Fig.3 and 4). CaMKII, a well-known modulator of LTCCs, is upregulated under 
pathological conditions26, 46, resulting in increased LTCC Po42. We extended these finding to show that 
CaMKII dependent phosphorylation of LTCCs is increased specifically in crest microdomains (Fig.3 and 
4) without affecting TT domains. CaMKII also contributed to the occurrence of abnormal calcium 
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oscillations and lethal arrhythmias (Fig.4, 6, and 7). CaMKII is a therapeutic target, and CaMKII inhibition 
provides cardioprotection26, 47. Using experiments and simulations, we elucidated an additional mechanism 
for the success of CaMKII inhibition in ameliorating HF, namely the inhibition of phosphorylation of 
dislocated LTCCs48. It has been shown that in HF the ICaL current peak density is not changed, whereas 
LTCCs density is decreased, suggesting an increase in the activity of the channels42. We propose that the 
dislocated LTCCs found on the crest can be modulated by CaMKII which could represent a new mechanism 
explaining this discrepancy.  
 
CaMKII mediated phosphorylation is an essential signaling event in triggering Ca2+/CaM-
dependent LTCC facilitation which requires the presence of LTCC β-subunits which can also be directly 
phosphorylated by CaMKII49. -subunits are up-regulated in human failing myocardium and their 
overexpression correlates with an increase in the Po of LTCCs50. Thus, we suggest that in failing myocytes, 
where the loss of TT structure is associated with dislocation of LTCCs to the crests, increase in CaMKII 
activity would phosphorylate and trigger facilitation of the dislocated LTCCs via two factors: the weak CDI 
in this microdomain and direct phosphorylaton of LTCC β-subunits, leading to an abnormal LTCC activity.  
 
Linking sub-cellular changes to arrhythmia propensity in HF. 
 
Using a new modelling approach spanning from stochastic LTCC gating to arrhythmogenesis at 
the organ level, we were able to understand how the subcellular changes are able to influence development 
of arrhythmias. We found that the increase in LTCC Po though CaMKII hyperactivity is specific to the crest 
microdomain (Fig.2), and this produces an increase of the slow inactivation of the ICa,L in failing cells 
(Fig.5B), as described previously in a stochastic model51. Recently, Morotti et al. using a mathematical 
model of rabbit action potential linked a decreased CDI to an increase of the slow inactivation of the ICa,L 
and the occurrence of EADs52, which was also observed in the present study. 
 
We demonstrated that in the failing ventricle, microdomain, cell and tissue level abnormalities act 
in synergy to produce whole organ arrhythmia. It is important to note that HF is a systemic disorder in 
which affects all of these hierarchical biological levels. For accurate representation of a human HF 
remodeling process, the membrane model of HF presented in this work used the descriptions provided in 
Elshrif et al.53 to define the rest of HF ion channel remodeling, outside of ICa,L. Our study confirms that 
CaMKII is an important node in this network of changes in the link between HF and arrhythmias. It is 
involved in disease pathways though the phosphorylation of multiple key proteins, modulating ion channel 
functioning and effecting gene transcription, metabolism and cell survival54, 55. It has also been linked to 
the HF-associated up-regulation of the late sodium current, an important contributor to EAD development56, 
57. Although many ionic currents can contribute to EAD formation in the settings of HF-associated 
remodeling, ICa,L late appearance plays a central role in providing a regenerative inward current required 
for EADs to propagate58, 59, thereby causing triggered activity in multicellular tissue60. It has been recently 
shown that reducing the amplitude of the noninactivating pedestal component of ICa,L (i.e. “late” or window 
ICa,L) effectively suppressed both H2O2- and hypokalemia-induced EADs61. In non-failing cardiac myocytes, 
in the settings of potassium current blockade, ICa,L was shown to be the main contributor to EADs 
formation62. Conversely in HF, enhanced late sodium current may also have an important role57, 63. It thus 
may indicate their additive role in the enhancement of these net inward currents during the plateau phase 
of the action potential, contributing to EAD development. 
 
Clinical implications. 
 
Conventional calcium channel blockers are generally felt to be contra-indicated in HF due to their 
negatively inotropic effects via inhibiting both peak and window ICa,L59. However such adverse effects may 
relate to non-specific targeting of LTCCs. The findings from this study can therefore facilitate the 
development of targeted and effective molecular therapies for preventing sudden cardiac death, without 
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harmful side-effects, and to steer the development of new and improved approaches to arrhythmia risk 
stratification of HF patients. In the future, our assay could be used as a development platform for improved 
therapeutic approaches in combating HF based on the subcellular distribution of their targets. For example, 
selective block of the non-native LTCC pathway—directly or through subsequent regulatory proteins, 
including CaMKII—by novel reagents might provide an effective strategy for predicting and ameliorating 
the risk of sudden cardiac death in patients with cardiac disease.  
 
Limitation. 
 
Failing cardiac myocytes were isolated from human tissue provided with the support of NIHR 
Cardiovascular BRU at Royal Brompton & Harefield from explanted failing hearts only. Control cardiac 
myocytes were isolated from human tissue provided with the support of Hammersmith Hospital from 
patients who underwent mitral valve replacement surgery, with normal ejection fraction values. This indeed 
may introduce a difference between samples due to the regional heterogeneity within the ventricles, 
however the differences in human cells between control and failing cases are consistent with the results on 
rat cells, which are isolated from the same region of the posterior lateral left ventricle free wall. Control 
human tissue for protein studies was obtained from the left ventricle free wall with the support of University 
of Sydney.  
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FIGURE LEGENDS 
 
Figure 1. TT loss in ventricular myocytes from failing human and rat hearts. (A) Example confocal 
images of human control and failing (top) and rat control and failing (bottom) cardiac myocytes showing 
membranes stained with di-8-ANNEPS, scale bar 10µm. (B) TT density in control and failing cells (human 
control n=20, failing n=8; rat control n=20, failing n=20; **P<0.01 by unpaired Student t-test). (C) Example 
SICM scans from a 10µm x 10µm portion of cell membrane shows regular undulations, indicating spatially 
alternating TT invaginations and surface membrane “Crests” in human (top left) and rat (bottom left) control 
cardiac myocytes, that are relatively absent in failing cells (right). (D) Z-groove index in human and rat 
failing cells normalized to control average value (human control n=30, failing n=59; top, P<0.01; rat control 
n=91, failing n= 122; bottom, P<0.001 by unpaired Student t-test). 
 
Figure 2. Abnormal LTCC localization and function in failing cardiac myocytes. Chance of obtaining 
a LTCC current (% occurrence) in human (A) and rat (B) control and failing cells (** denotes P<0.01 by 
Fisher’s exact test). Po during a maximum activating voltage step (to -6.7mV) in human (C) and rat (D) 
failing cells (human control, TT n=6, crest n=1; failing, TT n=6, crest n=9, *denotes P<0.05, **denotes 
P<0.01 by Mann-Whitney test) (rat control, TT n=19, crest n=4; failing, TT n=11, crest n=13, **denotes 
P<0.01, ***denotes P<0.001 by Mann-Whitney test ). Representative single channel traces at -6.7 mV 
showing LTCC activity in human (E) and rat (F) cardiac myocytes. 
 
Figure 3. LTCCs at crests in rat failing myocytes are hyperphosphorylated by Ca2+-calmodulin-
dependent protein kinase II (CaMKII). (A) Mean phosphorylated CaMKII (Thr286) from whole cell 
lysate in control and failing cardiac myocytes. A representative blot is shown above the graph. Results are 
normalized to α-tubulin (B) Mean p-CaMKII from whole tissue from control and failing human samples. 
A representative blot is shown above the graph. Results are normalized to GAPDH. (C) Mean p-CaMKII 
from whole cell lysate in failing cardiac myocytes with or without CaMKII inhibition. A representative blot 
is shown above the graph. Results are normalized to α-tubulin. (D) LTCC Po in control and failing rat 
myocytes, under control conditions and following CaMKII inhibition with 5 μM KN-93 or with 5 μM AIP  
(control TT n=19; control TT+KN-93 n=5; failing TT n=11; failing TT+KN-93 n=4; control crest n=4; 
failing crest n=13; failing crest+KN-93 n=9; failing crest+AIP n=3. * denotes P<0.05, ** denotes P<0.01 
by Kruskal-Wallis test).  
 
Figure 4. Ca2+ oscillations that develop in failing but not in control rat cardiac myocytes are CaMKII-
dependent. (A) Left, Spontaneous [Ca2+]i oscillation occurred at a pacing rate of 0.5Hz during the decay 
phase of calcium transients in failing rat cardiac myocytes only. Right, percentage of cells exhibiting Ca2+ 
oscillations (control n=106, failing =73, * denotes P<0.05 by Mann-Whitney test). (B) Left, Example of 
Ca2+ transients recorded from the same failing cardiac myocytes before and after treatment with KN-93. 
Right, Number of cells (in %) exhibiting Ca2+ oscillations (n=2 rats, 32-114 cardiac myocytes in each 
group; *denotes P<0.05 for failing vs. control; #P<0.05 for KN93 effect within the same group by Mann-
Whitney test). Saline mimics no treatment. 
 
Figure 5. Simulations demonstrated increased Po of LTCCs at failing Crest sites, as in experiments, 
and slowed inactivation. (A) Comparison between simulated and experimental Po values for 1s voltage 
steps to -6.7 mV (average of 500 stochastic sweeps in simulations). (B) Simulated whole cell TT and crest 
LTCC current (ICa,L) in control (black), and failing (red) cells. Traces in right column were normalized to 
allow visual comparison of decay rates. 
 
Figure 6. Simulations demonstrating the development of pro-arrhythmic triggers (early 
afterdepolarizations, EADs) in failing human ventricular (endocardial) myocytes. Rows from top to 
bottom show simulated action potentials, TT (black) and Crest (red) ICa,L, TT and Crest CaMKII activity 
(0.0 – none, no LTCCs phosphorylated; 1.0 – maximal, all LTCCs phosphorylated), and TT and crest Ca2+ 
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concentrations (i.e. concentrations in the dyadic and sub-sarcolemmal volumes). Columns from left to right 
show cases of control, failing, and failing cells with CaMKII block. 
 
Figure 7. Whole heart simulations predict the formation of arrhythmogenic triggers and reentrant 
arrhythmia in human heart failure. 1Hz pacing with a single skipped beat was from the apex. (A) Action 
potential traces at endocardial sites “i-iii” for control and failing hearts. Small dashed gray lines relate 
stimuli (solid gray tick marks) to resulting action potentials at the sites. In the failing heart, EAD triggers 
(red, arrows) appeared near site “ii” and propagated outwardly to other sites (gray lines emanating from 
EADs and triggered action potentials). Vertical semi-transparent bands denote time windows over which 
activation and voltage maps are shown in remaining panels. (B1 and B2) Activation maps, showing the 
time at which membrane voltage first crossed activation threshold, in the control and failing ventricles 
during the respective time windows B1 and B2 shown in panel A. (C) Progression of activation recovery 
during the time window C shown in panel A (from 4.0s to 6.0s, time points separated by 1/3s). An island 
of EAD generating tissue can be seen near site “iii” in snapshot 1. Reentry developed following the 
propagation of triggered activity emanating from the EAD site (path summarized in the cartoon at bottom 
right; arrows show general direction of propagation and should not be taken as belonging to specific 
wavefronts). 
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Novelty and Significance Section 
 
What Is Known?  
 
 Heart failure (HF) alters cardiac function as well as the functionality of ion channels.  
 
 Cells from HF models show a progressive loss of membrane structures and organization. 
 
 L-type calcium channels (LTCC) are considered an important component of alterations seen in HF 
cells. 
 
What New Information Does This Article Contribute? 
 
 Loss of structure in HF cardiac myocytes leads to redistribution of LTCCs. 
 
 Relocated LTCCs have different characteristics and may be a source of arrhythmias. 
 
 Translational modelling studies suggest that these specific LTCCs could be a potential drug target.  
 
 
HF is a complex and multifactorial disease. At the single cell level, HF causes hypertrophy, disorganization 
of the T-tubular structures, and alterations of ion channels profiles, including the LTCCs. To assess the 
impact of these alterations on ion channels, we studied isolated myocytes from the failing human heart.  We 
found that the loss of T-tubules leads to the redistribution of a portion of LTCCs on the cell surface. This 
redistribution leads to a dramatic increase in the activity of the LTCCs. They become a possible source of 
arrhythmias (due to the manifestation of early after depolarizations) and are partly controlled by the increase 
in the CaMKII activity seen in HF. We extrapolated these findings observed at the single cell level to whole 
heart using mathematical modeling, to deduce the consequence of the redistribution of LTCCs on the 
propagation of arrhythmias. Our results suggest that non-physiological ion channels in specific 
microdomains could be novel therapeutic targets in HF.  
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SUPPLEMENTAL MATERIAL 
 
Microdomain-Specific Modulation of L-type Calcium Channels Leads to Triggered 
Ventricular Arrhythmia in Heart Failure 
Jose L. Sanchez-Alonso, Anamika Bhargava, Thomas O'Hara, Alexey V. Glukhov, Sophie 
Schobesberger, Navneet Bhogal, Markus B. Sikkel, Catherine Mansfield, Yuri E. Korchev, 
Prakash P. Punjabi, Viacheslav .O. Nikolaev, Natalia A. Trayanova, Julia Gorelik 
 
1. Heart failure rat model and rat cardiomyocyte isolation 
Adult male Sprague-Dawley rats (250-300g) underwent proximal coronary ligation to 
induce chronic myocardial infarction as described before.
1, 2
 Briefly, rats were anesthetized 
with 2% isoflurane, intubated, and ventilated after preoperative buprenorphine (0.03 mg/kg 
SC) injection. The thorax was shaved and sterilized with 2% w/v chlorhexidine gluconate in 
70% v/v isopropyl alcohol. A left thoracotomy was performed, and the left anterior 
descending coronary artery was ligated with 6-0 silk. Sham ligation was used as control. 
Sixteen weeks later, in vivo PV analysis was performed using the 2-F Millar 
microconductance catheter (SPR838; Millar Instruments) via an apical approach under 
isoflurane (1.5%) anesthesia. Steady-state data (left ventricle end systolic and diastolic 
dimensions, and left ventricle ejection fraction) were recorded after 15 minutes’ stabilization. 
Data were recorded using CHART 5.5 software (AD Instruments) and analyzed off line using 
PVAN 3.6 software (Millar Instruments). Hearts were explanted, weighed, and prepared for 
cell isolation.  
This heart failure model recapitulates many features of chronic heart failure in patients 
including adverse remodeling of the organ, characterized by left ventricle and left atria 
dilatation, reduced ejection fraction, raised filling pressures and elevated serum natriuretic 
peptides.
2-4
 In particular, heart failure rats exhibited left ventricle dilatation, reduced ejection 
fraction and increase in the cell length (Online Figure I). Ventricular cells from this model 
have been studied extensively and are well characterized at structural, biochemical, 
molecular, Ca
2+
 handling, and electrophysiological levels.
2, 4, 5
 
Ventricular cardiomyocyte isolation was done as previously described.
1
 Briefly, 
Sprague-Dawley rats (150–250 g) were anesthetized with 5% isoflurane-95% O2 and then 
killed by cervical dislocation. Hearts were fast extracted and placed in Tyrode solution 
containing in (mmol/L): 140 NaCl, 6 KCl, 1 MgCl2, 1 CaCl2, 10 glucose and 10 HEPES, 
adjusted to pH 7.4 with 2 mmol/L NaOH. Using aortic cannulation with the Langendorff 
setting, the hearts were perfused with Tyrode solution for 5 min, then with low Ca
2+
 solution 
containing in (mmol/L): 120 NaCl, 5.4 KCl, 5 MgSO4, 5 sodium pyruvate, 20 glucose, 20 
taurine, 10 HEPES, 5 nitrilotriacetic acid, and 0.04 CaCl2, adjusted to pH 6.96 with 2 mmol/L 
NaOH  for 5 min, and finally for 10 min with enzyme solution containing in (mmol/L): 120 
NaCl, 5.4 KCl, 5 MgSO4, 5 sodium pyruvate, 20 glucose, 20 taurine, 10 HEPES, and 0.2 
CaCl2, pH 7.4 with collagenase (1 mg/ml; Worthington) and hyaluronidase (0.6 mg/ml; 
Sigma-Aldrich).  
Cardiomyocytes were plated on dishes coated with laminin and left to stick to bottom for 
at least 45 minutes before experiments. Cardiomyocytes were used on the same day as 
isolation. 
 
2. Patients groups and human cardiomyocyte isolation 
To control for factors of regional-dependent heterogeneity, the presence of acute 
ischemia, and ischemic injury, the current study was conducted on dilated end-stage 
cardiomyopathic human hearts (n=6, patients, average age 48±5 years, two females and 
fourth males, Online Table I) with the approval from Bromton Harefield & NHLI Research 
Ethic Committee (Ref 01-194). For comparison, we used ventricular left-over specimens 
obtained with the consent from non-failing patients (n=5, average age 69±2 years, two 
females and three males, Online Table II) during valve replacement procedure at 
Hammersmith Hospital, Imperial College London, London, UK. Although non-failing control 
patients were complicated by various factors, including age, early stage hypertrophy, atrial 
fibrillation, and coronary disease, they possessed normal left ventricle function (ejection 
fraction >60%).  
Failing ventricular cardiomyocytes were isolated from the apical section of the posterior-
lateral left ventricle free wall by enzymatic digestion as previously described.
2
 Briefly, 
individual specimens were transferred to ice-cold calcium free Krebs-Ringer saline solution 
consisting of (in g/L): 7.012 NaCl, 0.402 KCl, 1.332 MgSO4, 0.55 Pyruvate, 3.603 Glucose, 
2.502 Taurine, 2.383 HEPES, 1.286 Nitrillotriacetic Acid; pH = 6.96. Connective and 
adipose tissue were removed and approximately 500 mg of myocardial tissue was minced 
with razor blades in small cubes (approx. 1-2 mm
3
). Then, the tissue pieces were washed with 
fresh Ca
2+
-free Krebs-Ringer solution 3 times for 3 min each at 37
o
C. After wash, cardiac 
tissue was incubated for 25 min in 10 ml of Krebs-Ringer solution containing (in g/L): NaCl 
7.012, KCl 0.402, MgSO4 1.332, Pyruvate 0.55, Glucose 3.603, Taurine 2.502, HEPES 
2.383; pH = 7.4, supplemented with 200 nM CaCl2 and Proteinase type XXIV (0.36mg/ml; 
Sigma-Aldrich) under gentle agitation. The partially digested tissue was transferred to 10 ml 
of Krebs-Ringer saline supplemented with collagenase type XIV (1mg/ml Sigma-Aldrich). 
The tissue was incubated thrice with this solution for 10 min each at 37
o
C with gentle 
agitation. Usually, cardiomyocytes were visible by phase contrast light microscopy after the 
first incubation step, with the biggest amount of cells after the second incubation step. After 
each incubation step, the supernatants were transferred to a tube and centrifuged at 600 rpm 
for 3 min. The pellets were re-suspended in 2-3 mL of Krebs-Ringer solution. After isolation, 
human cardiomyocytes were plated following the same protocol as rat cardiomyocytes. Non-
failing control human ventricular cardiomyocytes were isolated from the left ventricle 
papillary muscles. 
 
3. T-tubule labelling and analysis 
Di-8-ANEPPS was excited at a wavelength of 488 nm and confocal images were taken at 
63x magnification using a Zeiss LSM-780 inverted confocal microscope. The 40x5 microns 
size area inside the sarcolemma that did not coincide with the cell nuclei was chosen, 
automatically thresholded into binarised, and the TT density was determined as ratio of black 
pixels versus white pixels. The TT regularity was calculated through a single dimension 
Fourier transformation using a custom-written macro for Matlab (The MathWorks, Inc., 
Natick, MA, USA) as described before.
6
 
For the visualization of the TT network structure in combination with SICM, 
cardiomyocytes were stained with the fluorescent dye Di-8-ANEPPS (10µM) for 1 min. Di-
8-ANEPPS was excited at a wavelength of 473 nm with a StradusTM473 laser (Vortran) and 
confocal images were taken at 100x magnification using a Photomultiplier Detection System 
(PTI). 
 
4. Super-resolution scanning patch-clamp with pipette clipping modification 
This technique combines scanning ion conductance microscopy (SICM) and patch-clamp 
electrophysiology with a pipette clipping modification to increase the throughput of recording 
ion channel activity from cell surface microdomains. SICM uses a sharp pipette (~100 nm 
inner diameter, ID, 100 MΩ resistance) as a scanning probe to generate high resolution 
topography images of live cells.
7
 SICM is based on the principle that the ion current through 
the electrolyte-filled micropipette is partially occluded when the pipette approaches the 
surface of a cell.
8
 Therefore, the position of the tip of the pipette relative to the cell surface 
strongly influences the ion current through the pipette. This ion current is digitized and fed 
into the feedback and scan control system which provides the feedback signal to control the 
vertical position of the pipette keeping the pipette-sample separation constant. The pipette 
raster scans the sample and generates a 3D topography image of the cell surface. 
Next, to clip the pipette tip to generate a wider pipette necessary to increase the chances 
of getting an ion channel, the pipette is positioned above a free surface away from cells. 
Then, moving down with high velocity the pipette is allowed to impact onto the surface and 
the tip of the pipette clips in a controlled manner.
7
 This is possible because at a high enough 
velocity of approaching the surface the feedback control of the scanning system cannot 
generate enough upward movement of the piezo-drive quickly enough to avoid contact with 
the surface. With this method at 500 nm/ms the pipette tip is clipped to approximately ~350 
nm ID, 30 MΩ resistance. The pipette is then positioned back onto the cellular microdomain 
of choice (in this case T-tubule or crest) taking help of the coordinates from the image 
acquired before clipping. The feedback is turned off; pipette is lowered until it touches the 
cell surface and a very gentle suction is applied to form a gigaseal (Online Figure II). Cell-
attached single channel recordings are then performed by the conventional patch-clamp 
technique. 
 
5. Electrophysiological recordings 
5.a. Cell attached LTCC 
Cell-attached patch-clamp recordings of single LTCC currents were performed at room 
temperature using the following solutions; external solution containing in (mmol/L): 120 K-
gluconate, 25 KCl, 2 MgCl2, 1 CaCl2, 2 EGTA, 10 Glucose, 10 HEPES, pH 7.4 with NaOH, 
~290 mOsm; internal recording solution containing in (mmol/L): 90 BaCl2, 10 HEPES, 10 
Sucrose, pH 7.4 with TEA-OH, ~250 mOsm. The pipette used for cell attached recordings 
had a typical resistance of approximately 30 MΩ. Currents were recorded using Axopatch 
200A amplifier (Axon Instruments, Foster City, CA, USA), controlled and monitored using 
pClamp software version 10 (Axon Instruments). Single LTCCs were identified and 
characterized by their voltage dependent properties. To generate a current-voltage (I–V) 
relationship, the membrane under the patch was held at a voltage of -80 mV and voltage 
pulses were applied from -30 to +30 mV in the incremental steps of 10 mV. Analysis was 
performed as previously described.
7
 Single channels were sampled at 10 kHz and filtered at 2 
kHz (- 3 dB, 8-pole Bessel). Single channel data were analysed using Clampfit version 10.2. 
A liquid junction potential, calculated to be -16.7 mV, was corrected from the data shown.  
Every time a channel is recorded a minimum of 100 sweeps at -6.7 mV (after liquid 
junction potential correction) and 3 full protocols at different voltage steps were done. All the 
sweeps are checked for the presence of more than one channel. When no second level of 
spikes is observed in any of the sweeps the recording is classified as one channel. Overall, 
from 89 recordings showing activity in this work, 70 (79%) of them were classified as one 
channel, 13 (14%) show two channels, 5 (6%)  triple channels, and only in one occasion (1%) 
the recording showed 4 channels, and this is similar  between TT and Crest regions. From 22 
recordings of human cells 64% were classified as one channel versus rat cells where from 67 
recordings 84% were classified as one channel. Seal data is showed in detail on Online Table 
III. 
Occurrence of LTCCs was calculated as the percentage of recording showing activity 
versus the total number of recordings, higher occurrence can be interpreted as a higher 
density of channels on that specific location or group.  
The open probability (Po) was averaged from 10-20 sweeps at -6.7 mV for each cell. 
Each cell was recorded only once, and only one value of Po per cell was used. The total 
number of channels in the recording was input into pClamp software to calculate the Po and 
the peak current (calculated as the overall average current) of one single channel. 
 
5.b. Action potential recordings  
 APs were recorded from isolated LV rat cardiomyocytes using the current-clamp 
configuration of the patch-clamp technique (Figure S12) with the external recording solution 
containing (mmol/L): 120 NaCl, 5.4 KCl, 0.2 CaCl2, 5 MgSO4, 10 HEPES,  20 glucose, 5 
pyruvate sodium, 20 Taurine, pH 7.4 with NaOH, ~300 mOsm, and the internal pipette 
solution containing (mmol/L): 120 KCl, 5 EGTA, 10 HEPES, 0.5 MgCl2, 1 CaCl2, 5 Mg-
ATP,  pH 7.3 with KOH, ~290 mOsm. Currents were recorded using Multiclamp 700B 
amplifier (Axon Instruments, Foster City, CA, USA), controlled and monitored using pClamp 
software version 10 (Axon Instruments). Patch pipettes had typical resistances of 8-10 MΩ. 
The bath was connected to the ground via an Ag–AgCl pellet. Data were sampled at 10 kHz. 
All recordings were performed at 33-35°C. APs were elicited with 5-ms current pulses at 
1Hz. AP characteristics were analysed using pClamp software.  
 
 
5.c. Whole-cell ICaL  
 Macroscopic Ca2+ currents were recorded using the whole-cell patch-clamp technique 
(Figure S13) with the external recording solution containing (mmol/L): 1 CaCl2, 0.5 MgCl2, 5 
HEPES, 140 choline chloride, 5 CsCl, 5.5 glucose, pH 7.4 with CsOH, ~305 mOsm, and the 
internal pipette solution containing (mmol/L): 130 Cs-methanesulphonate, 11 EGTA, 10 
HEPES, 2 MgCl2, 5 Mg-ATP, 0.3 Na-GTP, pH 7.2 with CsOH, ~290 mOsm. Currents were 
recorded using Multiclamp 700B amplifier (Axon Instruments, Foster City, CA, USA), 
controlled and monitored using pClamp software version 10 (Axon Instruments). Patch 
pipettes had typical resistances of 1–2 MΩ. The bath was connected to the ground via an Ag–
AgCl pellet. Data were low-pass filtered at 2 kHz using the built-in Bessel filter of the 
amplifier and sampled at 10 kHz. The amplifier was also used for capacitive transient and 
series resistance compensation between 60 and 70% on each cell. Leak subtraction of leakage 
currents was performed with Clampfit during off-line analysis. All recordings were 
performed at 33-35°C. I–V relationships were obtained by holding the cells at a potential of 
−50 mV before applying 100 ms pulses to potentials from −70 to +40 mV every 5s in 10 mV 
increments. I–V relationships were fitted with the modified Boltzmann equation, I = [Gmax× 
(Vm−Erev)]/{1 + exp[(Vm−V0.5a)/Ka], where Vm is the test potential, V0.5a is the half-
activation potential, Erev is the extrapolated reversal potential, Gmax is the maximum slope 
conductance and Ka reflects the slope of the activation curve.  
 
 
6. Single Channel Human L-type Ca
2+
 Current (ICa,L) 
6.a. Markov Formulation 
Human ventricular cell electrophysiological behavior was represented by the O'Hara-
Rudy model,
9
 selected because L-type Ca
2+
 current, ICa,L, in the model was based on un-
diseased human data, and because accurate representations of heart failure ion channel 
remodeling in transmural cell types of the model are available. The O’Hara-Rudy ICa,L 
follows the Hodgkin-Huxley (HH) formalism. However, we needed to model stochastic 
single channel behavior so that we can determine the channel open probability (Po) for 
comparison with human experimental data. We thus converted the HH ICa,L model to its 
Markov-equivalent representation. 
Online Figure IV shows the Markov equivalent of the O'Hara-Rudy ICa,L. There are 
32 states in each of the CaMKII un-phosphorylated and CaMKII phosphorylated modes (64 
total states). In each mode, there are 6 open states. Nested cubes in each mode are identical, 
except for open states, and include activation/deactivation by the “d” gate (right/left) and 
inactivation/recovery by the “f” (up/down) and “fca” (in/out of page) gates. The inner- and 
outermost pairs of nested cubes are connected by the slow recovery “jca” gate. The gate 
“nca” is Ca2+-sensitive and specifies whether inactivation is voltage (“f”), or Ca2+ (“fca”) 
driven. The innermost cube connects with the third cube, and the second cube connects with 
the outermost one via the “nca” gating. Thus, the four discrete combinations of “jca” and 
“nca” define the four nested cube (from innermost to outermost cube: jca=1, nca=0; jca=0, 
nca=0; jca=1, nca=1; jca=0, nca=1). 
Both “f” and “fca” gates have fast and slow gating modes. CaMKII un-
phosphorylated channels inactivate in both fast and slow gating modes. Inactivation occurs 
via the slow mode only for channels phosphorylated by CaMKII. 
6. b. Stochastic Sweeps using Gillespie Exact Algorithm 
 To evolve the channel gating in response to a 1-s voltage change step to -6.7 mV 
(from resting state, marked *), we used the Gillespie Exact Algorithm, implemented in 
Matlab (The Mathworks Inc.). The built-in pseudo-random number generator function, 
“rand”, was seeded to the system clock and used twice at each state change step, as required 
by the algorithm. Example single channel sweeps are shown in Online Figure VIII. 
6. c. Reverting to Hodgkin-Huxley Formalism 
 Once single channel current simulation results were generated and validated with 
experimental Po measurements, the ICa,L model was reverted back to an HH formulation. The 
HH formulation retained the CaMKII mode definitions and the behavior of the equivalent 
Markov version, but could be numerically integrated rapidly and with ease in cell (the 
O'Hara-Rudy model) and tissue simulations. Failing Crest LTCCs were assumed to operate in 
CaMKII phosphorylated mode, based on experimental findings. Their inactivation was 
strictly via the slow gating mode. Failing LTCCs in TTs and control LTCCs were sensitive to 
standard CaMKII levels in the cell, and so inactivation was both fast and slow. Ensemble 
current computed by summation of single channel sweeps matched the deterministic HH 
current, as expected (Online Figure V). 
 
7.  Models of Human Control Nonfailing and Failing Ventricular Myocytes 
7. a. Fast Na
+
 Current (INa) 
As noted online in the PLoS Computational Biology comments associated with the 
O'Hara et al. 2011 publication of the O'Hara-Rudy ionic model,
9
 we replaced the original INa 
with the formulation used in the ten-Tusscher et al human ventricular cell model.
10
 The ten-
Tusscher et al formulation was based on the same set of human experimental data. The ten-
Tusscher et al myocyte model and its INa have been used extensively to simulate action 
potential propagation in tissue (e.g. 
11, 12
). 
7. b. Sub-sarcolemmal Volume 
In the Grandi et al human cell model,
13
 SL volume was 0.0308 times that of the bulk 
myoplasm and 3.7106 times that of the dyad (or junctional) volume. However, bulk to dyad 
volume ratio is different in the Grandi et al and O’Hara-Rudy models. The Grandi et al model 
definition could be directly adopted by the O'Hara-Rudy model as either the ratio of bulk 
myoplasm volume to SL volume, or as dyadic volume to SL volume. In this study, SL 
volume in the O'Hara-Rudy model was set to be the average of these two options (0.04755 
times the whole cell volume). 
As was done by Grandi et al and Shannon et al, we set the flux rate between SL and 
myoplasm to be 0.2213 times that between dyad and SL. We assumed that the geometry of 
the dyad/SL interface was identical to the original O’Hara-Rudy dyad/myoplasm interface. 
Ca
2+
-dependent inactivation (CDI) of ICa,L occurs regardless of Ca
2+ 
origin, whether 
from Ca
2+
 release from RyRs in the dyadic volume or from the channel’s own flux. The 
original O'Hara-Rudy myocyte model did not include a sub-sarcolemmal (SL) volume and 
thus did not allow for Ca
2+
 accumulation near the intracellular mouth of Crest LTCCs. In the 
human ventricular cell model by Grandi et al.,
13
 an SL volume was included (originally 
incorporated in the Grandi et al model predecessor, a rabbit ionic model by Shannon et al 
14
). 
We incorporated SL volume and related fluxes in the O'Hara-Rudy myocyte model based on 
the work of Grandi et al and Shannon et al.
13, 14
 
As was done by Grandi et al and Shannon et al, we set the flux rate between SL and 
myoplasm to be 0.2213 times that between dyad and SL. We assumed that the geometry of 
the dyad/SL interface was identical to the original O’Hara-Rudy dyad/myoplasm interface. 
7. c. LTCC Current Density at TT and Crest Locations 
The original O'Hara-Rudy model included LTCCs exclusively at TT sites with dyadic 
intracellular face. In the present simulations, LTCCs in the TTs sensed and contributed to 
dyadic Ca
2+
; channels newly added to the Crest sensed and contributed to SL Ca
2+
. Channel 
kinetics and all equations governing behavior were identical in TT and crest. That is, changes 
in current function were solely based on extrinsic environmental changes, not intrinsic 
changes in kinetics. 
In each of TT and crest locations, LTCC permeability, PCa, representing whole-cell 
current density in TTs (PCaTT) and crest (PCaCrest) needed to be defined. We utilized 
experimental data obtained in this study to assign values to PCaTT and PCaCrest in control and 
failing human cells. The data used were: % occurrence of LTCCs, LTCC single channel 
current amplitude, and in failing cells, the degree of TT loss. Thus, we arrived at the 
following values for fractional PCa (fPCa) in control cells: fPCacontrol,TT = 0.75 and 
fPCacontrol,Crest = 0.25 (see manuscript Figure 2A). The original O'Hara-Rudy model PCa 
value was multiplied by these fractions to get accurate current density at TTs and crest in 
control myocytes. 
Values for fractional PCa (fPCa) in control cells were: fPCacontrol,TT = 0.75 and 
fPCacontrol,Crest = 0.25 (see manuscript Figure 2A). The original O'Hara-Rudy model PCa 
value was multiplied by these fractions to get accurate current density at TTs and crest in 
control myocytes. 
In failing human cells, our experimental findings (data not shown) indicated that 
LTCC single channel amplitude was slightly, but statistically significantly greater in TTs (1.2 
± 0.07 -fold greater) and slightly but statistically significantly lower at crest sites (0.85 ± 0.06 
times) when compared to control TT amplitude, the later being our reference amplitude.  
Thus, the LTCC % occurrence (as a fraction of total LTCC occurrence), (manuscript Figure 
2A), was multiplied by these single channel amplitude factors (1.2 and 0.85 for TT and Crest, 
respectively). For failing Crest, this was fPCafailing,Crest = 0.75*0.85 = 0.63. 
To arrive at a value for fPCafailing,TT, an additional factor accounting for the degree of 
TT loss was incorporated. This was necessary because TT loss reduces whole cell density of 
LTCC TT channels, which lowers fPCafailing,TT. Loss of TTs in failing human myocytes was 
the average of fractional TT density (failing/control = 0.51 ± 0.08) and fractional Z-groove 
ratio (failing/control = 0.41 ± 0.06, average of 0.54). Thus, fPCafailing,TT = 0.75*1.2*0.54 = 
0.486. 
Finally, experimental evidence from human myocytes has indicated (see for example 
15
) that HF ion channel remodeling does not have an effect on peak ICaL. Therefore, we 
adjusted the whole cell LTCC peak current in failing myocytes to match that of control. 
In summary: 
PCacontrol,TT = 0.75 
fPCacontrol,Crest = 0.25 
PCafailing,TT = 0.3846 
fPCafailing,Crest = 0.4985 
 
7. d. Na
+
/Ca
2+
 Exchanger (NCX) 
The original O'Hara-Rudy model assumes that 20% of NCX channels reside on the 
surface membrane. In the present simulations, the percent of NCX residing at crest sites (i.e. 
non-TT-residing NCX) was increased in accordance with the degree of TT loss, assuming 
that NCX migrates to the Crest in a way similar to LTCCs migration following TT loss. Since 
the value for the fraction of intact TTs was 0.54 (see above), 46% (100%-54%) of the original 
80% of NCX residing in TTs were relocated to the Crest in failing myocytes. The importance 
of accounting for NCX re-distribution following TT degradation arises from the fact that it 
affects concentrations in the SL volume. 
7. e. “Orphaned” RyRs 
With TT loss, the association between LTCCs and RyRs is also lost, affecting Ca
2+
 
induced Ca
2+
 release. The “orphaned” RyRs generate poorly coordinated Ca2+ release 
events.
16
 This was represented in the HF myocyte model by defining the ICaL trigger as ICaL,TT 
and by restricting RyR flux (“Jrel”) to the portion of remaining TTs (i.e. to 54% of the 
original number of TTs). This resulted in weakening of the trigger/response coupling between 
LTCCs and RyRs in failing cells, and in turn, affected LTCCs either directly or indirectly 
based on Ca
2+
 in their TT of Crest location, respectively. 
A more biophysically accurate and complete representation of RyR orphaning 
requires high sub-cellular spatial resolution not captured by the common pool dyadic volume 
in the O'Hara-Rudy model. Such representations are required for simulation of Ca
2+
 waves, 
which can occur in failing myocytes, but are not the focus of this study. The above, more 
phenomenological representation of RyR orphaning kept the focus of this research on LTCCs 
in the failing cell, and enabled implementation of the myocyte model in an organ-level 
electrophysiological model to study the downstream electrophysiological consequences. i.e. 
arrhythmogenesis. 
7. f. Heart Failure Remodeling 
A recent publication provided a comprehensive literature review of heart failure 
remodeling data in the human myocyte and a summary of how the data have been used in 
previous computational models.
15
 The publication used the O'Hara-Rudy model and 
presented endocardial and epicardial transmural definitions of heart failure ion channel 
remodeling, implemented as scaling of conductances to best represent the human dataset. We 
used the descriptions provided in Elshrif et al. (
15
, table 2) to define the rest of HF ion 
channel remodeling (outside of ICa,L) in our model.  
Holzem et al.
17
 examined rapid delayed rectifier current (IKr) remodeling, providing 
new human data and a human myocyte model based on the Grandi et al framework; 
simulations of myocyte behavior in HF best matched experimental data when IKr magnitude 
was reduced by 50%. We used this value for IKr magnitude remodeling in the failing myocyte 
model in the present study. 
A ~3-fold increase in CaMKII activity has been reported in human failing versus 
control cells 
18
. In the failing myocyte model we thus assumed that CaMKII at Crest/SL sites 
was maximal, while in the rest of the failing cell it was multiplied by a factor of 3. 
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Online Figure I. 
 
Online Figure I. Characteristics of the rat model of heart failure. (A) Heart weight to 
tibia length ratio was significantly increased in heart failure (control n=8 vs. failing n=16, 
P<0.05). (B) Ejection fraction was significantly decreased in heart failure (LVEF, left 
ventricular ejection fraction, control n=6 vs failing n=14, P<0.001). (C) Cell size was 
significantly increased in heart failure (control n=20 vs. failing n=20, P<0.001). (D) Total 
arrhythmias, (P<0.001) (E) Complex ventricular arrhythmias (P<0.01) (F) VT % cases. 
 
 
 
 
 
 
  
Online Figure II. 
 
 
Online Figure II. Super-resolution scanning patch-clamp method. A topographical image 
of the cardiomyocyte generated by SICM with a 100 nm nanopipette. The inner tip diameter 
of the nanopipette is widened to ~350 nm by controlled clipping to increase the area of 
attachment. First, the pipette was navigated to an area free of cardiomyocytes, the fall rate 
was increased and pipette was allowed to impact on surface. As a result the pipette breaks its 
tip and increases its diameter because of the conical shape of the pipette. Pipette tip breaking 
resulted in stepwise increases of the pipette current as its resistance dropped. The breaking 
was automatically stopped by returning the fall rate to baseline (60 nm/ms) once the pipette 
current reached a desired level. After clipping, the pipette is lowered to a speciﬁc location 
(TT or crest) and a gigaseal is established. Single ion channels are recorded in cell-attached 
mode. Insets show the pipette tip size before and after clipping.  
 
 
 
Online Figure III. 
 
Online Figure III. Clipping procedure does not change pipette position. T-tubule location 
on the surface scan before (left) and after (middle) clipping. After clipping the pipette 
resistance (Rp) reduced from 120 MΩ to 38 MΩ. Surface deepness thresholding was used to 
visualize location of T-tubules before (green) and after clipping (red). Because the pipette 
was held vertically at all times, x, y coordinates of the pipette tip did not change. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Online Figure IV. 
 
 
 
 
Online Figure IV. State diagram of the Markov model equivalent of the O'Hara-Rudy 
Hodgkin-Huxley (HH)-formalism-based L-type Ca2+ current formulation. Vertices of 
nested cubes on the left show connected states in the non-CaMKII-phosphorylated model. To 
the right are CaMKII-phosphorylated model states, distinguished by 2.5-fold slower 
inactivation (“fCaMK” and “fCa,CaMK” in purple and pink are slower than “f” and “fCa” in red 
and orange, left). When CaMKII phosphorylated, inactivation followed “slow” rather than 
“fast” paths (indicated by thick “slow” and thin “fast” connections in purple and pink). 
Colors and directional descriptors below indicate correspondence between the HH-based 
gates and Markov state transitions, as drawn in the diagram. Open states are marked by black 
dots. 
  
Online Figure V. 
 
 
 
Online Figure V. Examples of random single channel current sweeps. The Gillespie 
Exact Monte Carlo Algorithm was used to calculate stochastic gating in response to a 1 s 
voltage step to -6.7 mV. Sweeps show early and infrequent openings without CaMKII (left 
column of sweeps) and frequent and late openings with CaMKII phosphorylation. 
  
Online Figure VI. 
 
 
 
Online Figure IV. Examples of summation of an ensemble of 500 stochastically gating 
LTCCs. Ensemble traces in red were compared with the deterministic HH-based current 
(blue), illustrating that the single channel model produces the expected results in response to 
a voltage step to -6.7 mV. 
 
 
 
 
 
 
 
Online Figure VII. 
 
 
 
Online Figure VII. Human heart control and failing computational models. (A) MRI-
based geometry of the human ventricular model. (B) Transmural cell types. (C) Transmural 
tissue conductivity values incorporated in the model, based on experimental data regarding 
transmural Cx43 distribution from human left ventricular wedges, as measured in Glukhov et 
al.19 2010. The values vary across the septum and free wall following the gradient pattern 
shown in panel B. 
  
Online Figure VIII. 
 
 
Online Figure VIII. TT openings decrease in failing cells. (A) Confocal and SICM images 
of the same 17.5 µm x 17.5 µm patch of membrane. The images demonstrate correlation 
between the two measurement modalities in both number and localization of TTs. In confocal 
images, di-8-ANNEPS staining (10 µM) marks the membrane. SICM images the membrane 
surface topology. (B) Left, SICM scans of a control and failing cardiomyocyte, black holes 
on the surface indicate TT openings. Right, Quantification of TT openings (control n=41 vs. 
failing n=44, P<0.001). (C) Top, power spectrum retrieved from a 2D Fourier transformation 
of confocal images of TT from a control and failing cardiomyocyte. Bottom, quantification 
of peak power values (in arbitrary units) at the dominant frequency (control n=11 vs. failing 
n=11, P<0.001). 
  
Online Figure IX. 
 
 
 
Online Figure IX. Increased LTCC activity in the crest of failing cells is not due to 
changes in current amplitude. (A) Voltage dependence of single LTCC currents in the TTs 
and in the crest of control and failing cardiomyocytes. (B) Representative single channel 
traces at indicated voltages. Downward deflections are opening of single LTCC and dotted 
line represents the closed level. (C) Single channel amplitude at -6.7 mV in control and 
failing rat cardiomyocytes at different locations. Amplitude was unchanged between all 
groups (control, TT n=19, crest n=4; failing, TT n=11, crest n=13). 
 
 
 
 
 
 
 
 
Online Figure X. 
 
 
Online Figure X. KN-93 blocker reduces LTCC activity in the crest of failing cells. 
Representative single channel traces at -6.7 mV showing single channel activity in the crests 
of control, failing, and KN-93-treated failing cardiomyocytes. Dotted line represents the 
closed level. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Online Figure XI. 
 
 
Online Figure XI. Effect of KN-92 on failing cardiomyocytes. Percentage of mapped cells 
that exhibited oscillations are shown for failing cells before and after treatment by KN-92 
(n=2 rats for each treated group). 
 
 
 
 
 
 
 
 
 
 
 
 
Online Figure XII. 
 
 
Online Figure XII. Action potential recordings and characteristics from control and 
failing rat cardiomyocytes. (A) Representative AP trace of a control (left) and a failing rat 
cardiomyocyte (right) after 5ms threshold pulse at 1Hz stimulation. (B) AP characteristics. 
Cm indicates membrane capacity. RMP indicates resting membrane potential. APA indicates 
action potential amplitude. APD indicates action potential duration at 50% and 90%. Values 
are mean±SEM. 
 
 
 
 
 
 
 
Online Figure XIII. 
 
Online Figure XIII. Whole cell L-type calcium current recordings from control and 
failing rat cardiomyocytes. (A) Whole cell ICaL current-voltage relationship of control and 
failing cardiomyocytes (control n=7, failing n=5). (B) Voltage dependence of the time 
constant of ICaL inactivation in both control and failing cardiomyocytes from A. * indicates 
p<0.05.  
 
 
 
 
 
 
 
Online Figure XIV. 
 
 
Online Figure XIV. Simulations of EADs in failing ventricular myocytes as a function of 
transmural cell type and pacing protocol. (A) Slow pacing at 0.25Hz did not result in 
EADs in control (left) or failing (right) human epicardial (epi) cells. (B) Pacing human 
endocardial (endo, far left is control, and second from left is failing) or epi cells (control and 
failing are second from right and far right, respectively) at 1Hz with a single skipped beat did 
result in EADs. (C) 1 Hz pacing with two skipped beats resulted in an EAD in failing human 
endo cells (second from left), but not in the other cases. 
Online Tables. 
Patient Diagnosis Age Gender NYHA BNP 
(ng/l) 
LV Post Wall 
Thick. Systole 
(mm) 
LV Post Wall 
Thick. Diastole 
(mm) 
HF#1 DCM 40 Male IV 2839 13 9 
HF#2 DCM 33 Male IV 624 10 8 
HF#3 DCM 57 Male IV 1525 10 8 
HF#4 DCM 56 Female IV 1543 7 6 
HF#5 DCM 64 Male IV 942 6 8 
HF#6 DCM 41 Male IV 588 10 7 
Online Table I. Heart failure patients characteristics. HF, heart failure; DCM, dilated 
cardiomyopathy; NYHA, New York Heart Association functional classification; BNP, B-type 
Natriuretic Peptide levels. 
 
Patient Diagnosis Age Gender 
NF#1 MVR 78 Female 
NF#2 MVR 69 Male 
NF#3 MVR 66 Male 
NF#4 MVR 70 Female 
NF#5 MVR 64 Male 
Online Table II. Control patients characteristics. NF, nonfailing; MVR indicates mitral 
valve replacement procedure. 
 
Group successful 
seal rate 
Total 
cells 
sealed 
Occurrence 
 (cells that show  
LTCC activity) 
Pipette resistance (MΩ) 
 
        TT                 Crest 
Control 
RAT 
76% 143 19% 32.34±0.85 30.48±1.41 
Failing 
RAT 
70% 99 26% 31.93±1.4 30.02±0.75 
Control 
HUMAN 
84% 33 22% 30.52±1.23 25.73±2.76 
DCM 
HUMAN 
75% 48 31% 33.32±1.49 25.64±1.16 
Online Table III. Patch-clamp single channels seals characteristics. Percentage of 
successful seals was calculated from the total number of seals tried after the clipping of the 
pipette. Overall, 7% of the pipettes were discarded after the clipping process and were not 
used for the analysis. Pipette resistance corresponded to an estimated inner tip diameter range 
of         260-425 nm for TT and 260-530 nm for Crest recordings.  
Online Videos 
Online Video I. Simulated failing human ventricular movie showing the formation of 
arrhythmogenic triggers and reentrant arrhythmia. (1Hz pacing with a single skipped beat 
after two pacing stimulus), after the skipped beat cells failed to repolarize and an endocardial 
EAD trigger formed. Note that the activation took twice as long to excite the failing 
ventricles when compare to control. 
Online Video II. Simulated control human ventricular movie showing organize and regular 
response to each pacing stimulus (1Hz pacing with a single skipped beat after two pacing 
stimulus). The skipped beat does not produce any effect on the control ventricle. 
 
